hg_238263.1

Basic information about the TSS

---

TSS ID: hg_238263.1 Species: human Chr: chr21		Start: 26170732 End: 26170734 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: X06989 Distance: -4 GeneID: 351 HGNC/MGI_ID: HGNC:620 UniProt_ID:

Gene_name: amyloid beta precursor protein Gene_symbol: APP Gene_synonyms: alpha-sAPP Gene_source: HGNC:620

TATA-Box annotation

---

Distance to TSS:	33
Nearest PromoterID:	NM_001269041
Entrez ID:	140690
Nearest Unigene:	Hs.131543
Nearest Refseq:	NM_080618
Nearest Ensembl:	ENSG00000124092
Gene Name:	amyloid beta precursor protein
Gene Alias:	BORIS|CT27|CTCF-T|HMGB1L1|dJ579F20.2
Gene Description:	CCCTC-binding factor like
Gene Type:	protein-coding
CpG%:	0.05
GC%:	0.711443
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@APP p3@APP p4@APP p6@APP p7@APP p10@APP
Sample		p1@APP	p3@APP	p4@APP	p6@APP	p7@APP	p10@APP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	127.79	1.17	1.17	1.17	0.19	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	133.73	2.02	1.82	0.81	0.61	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	141.01	2.51	0.58	0.77	0.58	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	112.48	0.62	0.62	0.00	1.04	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	122.38	0.67	0.45	0.00	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	119.58	0.78	1.55	0.78	0.78	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	167.12	0.87	1.31	0.87	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	138.31	0.48	0.97	0.73	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	143.62	0.85	0.85	1.07	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	104.33	0.00	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	101.46	1.21	0.40	0.40	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	105.70	0.81	0.41	0.00	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	467.62	8.87	4.03	3.06	1.29	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	404.29	6.92	2.10	2.10	1.95	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	415.18	6.37	3.51	1.98	1.98	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	382.27	11.82	4.28	3.02	2.77	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	367.80	8.95	2.40	0.66	1.31	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	401.99	13.08	4.64	5.91	2.95	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	355.61	8.00	4.27	1.07	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	343.01	8.88	3.46	1.20	1.65	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	418.20	9.76	2.67	2.00	1.20	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	371.31	6.21	2.76	0.52	1.55	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	378.72	6.85	3.88	1.03	1.29	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	377.35	10.43	2.67	2.18	1.70	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	369.18	10.32	2.58	1.81	2.32	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	386.46	11.39	4.43	0.63	0.95	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	345.61	13.19	4.40	0.00	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	375.55	9.43	4.95	3.06	0.94	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	342.11	9.37	1.29	0.48	1.13	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	322.84	7.06	3.08	2.53	2.17	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	346.05	14.65	2.30	0.21	1.26	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	331.56	9.57	1.17	0.59	0.78	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	361.28	13.93	1.48	0.21	1.48	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	308.93	9.07	3.46	2.14	0.99	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	311.90	11.22	3.55	1.50	1.12	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	351.82	6.71	4.41	2.87	1.92	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	336.21	13.08	3.88	1.43	0.82	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	307.67	7.66	3.43	1.81	1.21	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	364.10	9.18	4.05	2.70	1.08	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	339.69	8.16	1.92	1.44	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	326.31	12.00	4.00	1.18	1.65	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	322.95	6.88	1.32	1.32	0.59	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	303.26	8.86	1.69	1.05	1.05	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	367.49	7.52	2.10	1.05	0.87	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	355.37	7.83	2.61	1.41	0.80	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	357.11	11.40	4.89	2.33	1.63	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	342.11	10.56	2.40	1.20	0.48	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	328.75	7.15	0.89	1.19	1.79	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	321.96	10.05	1.91	0.48	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	291.37	6.27	1.01	1.42	0.81	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	349.86	9.22	3.89	1.02	1.84	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	350.02	11.34	4.89	2.45	2.89	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	4379.55	209.88	111.94	125.93	55.97	167.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	320.44	6.03	2.84	1.06	2.13	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	308.52	4.64	4.31	0.66	1.99	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	451.35	20.13	19.30	9.23	13.42	21.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	291.16	15.15	5.51	1.38	3.21	7.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	285.54	6.81	6.16	1.94	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	277.17	8.67	1.61	0.32	0.96	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	321.25	15.40	1.26	1.26	1.89	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	229.85	4.94	2.82	0.00	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	210.30	3.36	1.12	0.56	2.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	179.13	37.42	6.37	7.96	7.96	13.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	248.71	7.14	3.40	1.36	1.36	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	249.54	8.77	2.60	3.57	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	193.46	6.74	3.55	2.13	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2327.61	96.98	80.82	80.82	16.16	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2416.63	23.69	31.59	15.79	7.90	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	148.20	5.85	3.90	1.95	2.93	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	195.37	3.97	2.48	2.48	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	163.25	2.35	2.81	0.94	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	209.31	5.30	1.99	1.32	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	198.91	5.57	3.71	1.55	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	197.82	6.11	3.36	0.92	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	162.50	3.01	0.95	0.63	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	128.50	3.85	2.89	0.96	0.80	1.76
Adipocyte - omental, donor1	11473-119C6	175.07	3.56	0.76	0.25	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	133.80	3.74	1.49	0.75	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	142.01	4.35	1.67	0.33	1.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	116.11	1.28	2.55	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	56.07	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	135.04	1.81	1.35	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	116.43	1.04	1.74	0.17	0.52	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	324.45	2.93	0.78	1.17	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	281.57	0.77	4.38	1.29	1.29	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	436.56	1.67	1.95	0.56	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	272.74	1.18	2.35	1.18	2.35	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	224.17	0.56	1.21	0.72	0.64	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	274.34	0.97	2.58	0.97	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	234.60	1.60	4.80	3.20	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	193.64	1.67	0.56	0.00	1.67	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	108.13	0.00	0.83	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	182.60	1.51	1.76	1.00	1.26	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	158.39	0.65	1.31	0.33	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	124.83	0.61	0.91	1.22	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	129.95	0.66	0.22	0.22	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	44.82	0.36	0.72	0.00	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	89.85	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	330.85	1.08	1.44	0.54	0.90	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	259.39	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	259.89	0.82	2.47	1.64	1.23	0.21
Anulus Pulposus Cell, donor1	11248-116E6	283.78	0.92	0.92	0.23	0.46	0.34
Anulus Pulposus Cell, donor2	11463-119B5	199.35	1.71	1.47	1.96	1.47	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	282.61	8.99	5.39	5.39	0.45	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	319.96	9.12	6.08	3.47	2.17	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	327.46	14.98	12.84	4.28	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	272.92	9.86	6.88	3.89	2.99	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	369.28	2.53	5.06	5.06	3.79	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	234.32	5.28	3.30	1.98	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	278.10	4.87	6.50	1.30	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	330.10	2.43	7.28	0.97	1.46	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	267.25	7.13	4.75	2.38	2.38	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	293.02	13.18	7.91	1.13	2.26	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	297.53	2.90	5.81	2.18	1.45	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	223.17	6.27	10.03	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	388.45	4.12	2.14	0.49	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	320.73	8.19	8.19	5.46	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	286.65	5.43	1.51	0.90	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	323.08	3.75	8.04	1.07	2.14	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	316.28	3.97	4.53	1.51	0.76	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	345.87	4.54	5.61	1.34	2.67	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	300.44	7.80	6.83	0.98	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	308.83	4.98	3.48	1.99	1.00	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	230.54	3.60	2.40	4.80	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	410.66	7.08	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	306.01	7.03	6.18	2.40	1.20	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	285.26	16.78	12.58	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	333.97	3.88	7.77	2.43	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	327.85	4.55	5.69	1.14	1.52	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	290.73	15.75	8.48	1.21	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	346.01	5.70	5.13	2.28	1.71	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	335.41	4.92	4.49	1.50	1.50	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	291.90	3.61	3.61	2.06	2.32	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	297.95	6.10	7.98	1.88	0.47	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	265.92	10.29	3.54	2.89	1.29	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	218.32	4.28	1.43	0.00	2.85	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	267.91	8.77	4.68	2.34	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	301.07	9.03	4.22	1.51	0.90	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	257.79	4.75	5.94	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	291.40	5.09	6.10	3.56	1.02	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	271.24	13.24	8.15	2.55	2.80	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	214.12	8.26	3.81	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	299.48	10.36	2.59	0.86	2.16	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	247.04	5.72	2.12	1.91	1.27	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	236.05	4.06	4.64	0.58	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	293.81	5.67	1.89	1.89	3.78	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	269.04	4.92	3.22	1.02	1.36	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	296.49	6.95	6.95	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	390.83	8.45	2.11	4.23	4.23	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	302.75	6.22	4.07	1.07	2.14	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	305.04	7.22	7.82	0.60	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	314.19	3.64	2.19	2.19	1.46	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	285.97	4.60	3.45	2.76	1.61	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	331.54	25.50	17.85	10.20	5.10	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	335.84	5.34	1.78	0.25	1.02	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	361.89	4.75	3.92	1.45	0.41	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	287.33	4.59	7.34	2.14	3.06	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	370.46	4.30	9.56	3.35	4.30	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	323.52	5.99	5.10	2.66	2.44	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	244.13	10.68	0.00	3.05	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	309.62	7.20	6.65	2.22	0.55	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	339.73	3.97	6.36	2.38	1.32	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	257.68	7.63	5.45	2.91	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	235.07	1.23	0.86	0.37	1.11	0.37
Astrocyte - cerebellum, donor2	11580-120F5	141.55	0.51	2.23	0.68	0.86	0.34
Astrocyte - cerebellum, donor3	11661-122F5	191.50	0.21	1.47	0.84	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	427.02	2.09	3.14	0.70	1.39	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	273.88	3.72	3.56	1.29	1.94	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	273.26	1.49	2.24	1.19	1.49	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.17	0.46	1.03	0.34	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	48.86	0.38	0.25	0.25	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.93	0.23	0.23	0.23	0.00	0.11
Basophils, donor1	12241-129G9	72.18	0.00	0.26	0.52	0.00	0.26
Basophils, donor2	12242-129H1	86.95	0.00	0.36	0.36	0.00	0.00
Basophils, donor3	12243-129H2	109.22	1.32	0.00	0.15	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	287.83	1.72	0.65	0.65	0.86	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	86.87	0.00	0.46	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	602.58	7.17	14.35	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	139.34	0.63	1.88	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	210.86	0.00	1.25	0.62	1.04	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	191.14	0.23	2.99	0.92	0.92	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	468.58	6.12	8.82	3.42	3.60	4.86
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	132.07	0.64	0.32	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	227.52	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	96.93	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	92.43	0.93	0.74	0.56	0.00	0.56
CD14+ Monocytes, donor3	11381-118B4	82.77	0.22	0.66	0.66	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	83.50	0.85	0.57	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	53.45	0.38	0.00	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.17	0.00	0.00	0.33	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	96.85	0.87	1.01	1.01	0.29	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	85.09	0.30	0.30	1.21	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	75.57	0.47	0.47	0.00	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	88.55	0.67	0.67	0.84	0.17	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	81.70	0.55	0.28	1.38	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	69.92	0.74	0.50	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	95.75	0.98	0.59	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	90.63	0.89	0.53	0.89	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	96.19	0.44	0.44	0.00	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	92.48	0.94	0.47	0.23	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	107.19	1.58	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	78.76	0.00	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	88.65	1.78	1.64	0.30	0.74	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	79.82	0.80	0.00	0.20	0.00	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	61.63	0.00	0.00	0.00	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	91.29	1.60	0.69	0.92	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	89.80	0.23	0.23	0.23	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	78.13	0.44	0.44	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	100.06	0.54	0.81	0.27	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	109.74	0.70	0.70	1.22	0.87	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	106.89	0.00	0.84	0.00	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	88.18	1.29	1.10	0.37	0.18	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	85.25	0.35	1.06	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	80.29	0.44	0.00	0.44	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	95.21	0.35	1.39	0.70	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	100.35	0.74	0.74	1.49	1.49	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	109.50	0.43	0.43	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	90.50	0.41	0.41	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	92.72	0.46	0.23	0.23	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	70.76	0.23	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	42.29	0.44	0.00	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	55.44	0.92	0.46	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	48.52	0.43	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	141.86	0.62	0.16	0.16	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	158.23	1.22	0.35	0.35	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	182.61	0.67	0.67	0.89	0.45	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	23.73	0.00	0.00	0.51	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	37.98	0.44	0.44	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	31.37	0.21	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.92	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	51.78	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	71.96	0.00	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	58.97	0.00	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	69.49	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	60.40	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	76.46	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	65.75	0.82	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	71.82	0.73	0.00	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	68.15	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.89	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.59	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	61.25	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	79.21	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	121.37	0.75	0.38	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	128.53	0.00	0.00	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	85.34	0.36	0.00	0.00	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	64.91	2.45	1.22	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	63.13	0.30	0.30	0.61	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	22.72	0.26	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.05	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	28.75	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	55.47	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.72	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.82	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.63	0.17	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	7.58	0.16	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.45	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	19.22	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	17.16	0.00	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	23.61	0.42	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	22.02	0.83	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.72	1.00	0.33	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	79.13	0.82	0.54	0.27	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	122.20	0.00	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	68.14	0.00	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.07	0.19	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	6.30	0.00	0.21	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	46.52	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.92	0.00	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.07	0.44	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	19.39	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	54.55	0.00	0.28	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	62.57	0.00	0.25	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	54.43	0.00	0.36	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	16.37	0.00	0.00	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	10.89	0.00	0.38	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	23.48	0.50	0.25	0.00	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	48.63	0.00	0.23	0.00	0.00	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	45.77	0.72	0.48	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.69	0.55	1.09	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	44.13	0.00	1.20	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	55.68	0.48	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	51.16	0.23	0.23	0.00	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.23	0.65	0.43	0.22	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	51.85	0.79	0.00	0.00	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	52.53	0.70	0.47	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	50.72	0.30	0.30	0.30	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	46.19	0.29	0.29	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.03	0.53	0.53	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	47.28	0.00	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	47.82	0.00	0.46	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	38.79	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	57.62	0.36	0.00	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	55.82	0.29	0.29	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	49.50	0.00	0.24	0.24	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	58.94	0.00	0.63	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	59.97	0.92	0.31	0.00	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	56.42	0.00	0.32	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	48.19	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	39.80	0.79	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	0.00	1.51	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	70.66	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.24	0.70	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	94.16	0.00	0.00	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	157.19	0.00	3.66	18.28	10.97	3.66
Cardiac Myocyte, donor2	11605-120I3	277.68	2.96	1.98	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	291.60	1.79	0.42	0.32	0.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	118.56	7.28	0.35	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	130.07	0.00	1.42	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	127.09	4.44	1.37	0.46	0.57	0.23
Chondrocyte - re diff, donor2	11339-117F7	383.17	0.00	2.69	0.90	2.69	1.79
Chondrocyte - re diff, donor3	11411-118E7	174.70	3.64	2.43	1.21	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	349.44	1.61	2.41	1.15	0.69	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	270.20	1.92	3.42	0.86	2.57	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	265.23	1.95	1.77	1.42	1.24	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	578.08	1.19	3.67	2.84	2.29	0.73
Corneal Epithelial Cells, donor1	11526-119I5	170.83	0.44	0.22	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	236.62	3.41	1.14	3.41	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	173.83	0.26	1.02	0.51	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	318.30	1.65	1.16	1.16	1.32	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	324.24	2.52	1.89	1.26	0.95	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	386.48	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	242.87	2.05	3.78	0.86	0.54	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1428.74	4.44	3.07	2.39	2.73	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1448.72	0.65	1.31	0.00	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1678.80	1.94	4.84	0.97	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	347.55	0.17	0.67	0.67	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	417.20	0.59	2.35	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	436.92	3.39	1.70	1.13	1.41	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	669.59	0.79	4.33	2.75	5.90	0.00
Endothelial Cells - Artery, donor1	11264-116G4	524.74	4.65	2.04	1.45	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	447.50	7.06	4.71	1.41	3.76	3.29
Endothelial Cells - Artery, donor3	11413-118E9	361.49	0.35	3.16	1.58	1.58	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	1375.57	12.41	7.31	2.66	3.77	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	1491.21	9.43	4.87	3.35	5.48	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	1279.84	3.66	2.26	2.82	3.95	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	558.61	14.56	2.97	0.59	0.59	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	518.06	6.25	1.04	0.00	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	440.25	4.68	3.83	2.98	2.69	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	713.01	23.21	2.40	2.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	447.08	5.24	6.81	2.10	1.57	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1034.23	6.96	4.22	1.62	3.60	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	743.47	1.30	10.43	2.82	2.82	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	681.96	1.10	5.01	1.59	2.08	0.24
Endothelial Cells - Vein, donor1	11267-116G7	267.31	0.00	0.00	1.14	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	560.90	0.00	1.40	0.70	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	526.44	1.57	5.18	2.36	2.98	0.63
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	61.06	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	49.94	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	269.74	0.00	1.47	0.98	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	187.21	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	1122.55	0.00	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	304.19	6.98	3.28	4.93	2.87	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	179.78	2.52	3.18	3.83	2.96	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.92	0.22	0.22	0.00	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	240.50	4.97	1.82	0.49	0.97	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	613.71	8.46	0.68	1.09	1.50	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	391.82	7.91	4.96	1.90	2.95	1.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1305.33	21.08	11.07	4.48	4.74	6.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	239.85	3.99	2.33	2.66	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	171.02	1.36	1.81	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	164.47	1.52	0.76	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	143.36	1.26	1.58	0.63	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	406.16	1.52	0.91	1.21	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	396.19	1.78	5.58	1.27	2.16	1.02
Fibroblast - Cardiac, donor6	11460-119B2	285.15	1.82	2.58	1.06	1.82	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	465.48	2.81	1.34	0.40	0.67	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	307.18	2.59	3.45	2.59	2.16	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	309.07	7.32	7.32	1.46	1.46	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	208.50	0.00	0.00	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	431.64	2.20	2.88	1.02	1.36	0.68
Fibroblast - Dermal, donor1	11269-116G9	233.14	3.05	1.41	0.70	0.23	0.94
Fibroblast - Dermal, donor2	11346-117G5	243.86	0.94	1.42	0.47	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	195.35	4.96	1.93	0.97	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	145.83	0.79	2.15	1.02	0.57	0.34
Fibroblast - Dermal, donor5	11454-119A5	171.14	1.40	1.57	0.70	1.57	0.00
Fibroblast - Dermal, donor6	11458-119A9	191.50	1.62	1.79	0.16	0.97	0.49
Fibroblast - Gingival, donor1	11237-116D4	255.71	1.67	0.42	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	309.42	2.10	3.14	0.26	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	250.78	4.88	3.43	0.79	0.66	1.71
Fibroblast - Gingival, donor3	11394-118C8	303.60	0.68	2.42	0.87	0.48	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	292.97	0.00	1.04	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	197.00	2.64	4.05	2.29	1.76	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	147.01	0.31	1.09	0.78	0.47	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	151.05	1.22	1.62	0.54	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	111.86	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	160.28	1.46	1.46	0.58	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	186.94	1.36	1.23	1.09	0.41	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	129.11	0.44	1.10	0.33	0.77	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	379.61	3.08	4.11	1.03	1.47	0.59
Fibroblast - Lung, donor1	11270-116H1	101.95	1.36	0.00	2.72	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	189.50	4.48	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	149.62	1.90	1.69	0.42	1.06	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	179.10	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	169.23	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	40.58	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	310.57	0.00	0.41	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	103.85	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	196.56	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	201.34	0.97	0.97	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	196.12	1.06	2.43	0.30	1.06	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	245.10	1.53	0.92	0.61	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	140.44	0.76	3.43	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	164.42	1.62	4.05	1.08	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	210.26	0.70	2.78	1.04	1.16	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	209.24	1.77	0.77	0.66	0.66	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	196.69	0.20	0.20	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	128.30	1.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	185.03	1.19	1.98	0.79	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	474.09	10.72	1.19	1.19	1.19	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	404.97	3.02	1.95	0.71	0.71	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	274.15	4.14	1.38	0.59	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	450.68	8.12	2.41	0.60	0.90	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	263.08	1.73	1.30	0.76	0.76	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	414.54	4.30	3.29	0.51	1.27	1.77
Fibroblast - skin normal, donor1	11553-120C5	262.52	3.12	1.48	0.33	0.82	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	532.35	13.63	1.80	0.80	0.60	1.60
Fibroblast - skin normal, donor2	11561-120D4	210.67	2.61	0.90	0.60	0.60	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	378.70	8.46	1.21	0.91	1.21	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	406.44	5.22	1.74	0.91	0.91	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	518.32	4.10	3.93	1.20	1.71	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	705.14	16.09	3.61	1.31	1.31	4.27
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	248.20	2.98	1.38	0.64	0.21	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	157.55	3.37	0.34	0.67	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	125.30	3.76	3.45	0.94	1.57	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	205.68	4.36	6.10	3.49	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	903.71	11.44	5.55	1.91	3.29	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1305.11	15.61	1.82	3.12	2.60	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	893.27	8.18	1.28	3.07	0.77	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	265.65	1.53	2.30	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	280.75	1.91	1.91	1.28	3.19	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	490.37	8.84	8.84	4.28	3.42	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	278.51	7.72	4.41	1.10	0.83	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	271.25	5.71	3.88	1.37	1.60	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	414.69	8.92	4.16	2.77	0.99	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	272.79	6.34	3.97	1.06	0.79	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	237.76	5.22	2.61	0.33	0.98	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	395.79	7.96	5.31	3.10	2.21	4.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	470.89	2.97	4.95	2.12	1.27	2.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	439.49	2.22	5.42	3.57	2.34	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	286.62	2.95	2.42	1.61	2.15	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	374.65	3.59	2.85	1.24	0.62	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	481.45	4.01	4.98	2.63	1.80	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	334.03	1.83	3.25	1.42	1.02	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	325.84	2.28	1.83	0.91	0.46	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	426.01	2.87	4.86	1.87	1.12	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	384.91	2.84	4.59	1.31	1.53	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	285.14	3.84	2.95	2.07	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	442.22	2.86	5.72	2.86	1.91	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	369.09	2.90	1.56	1.12	1.79	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	297.01	2.02	2.62	1.41	1.41	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	440.39	2.54	5.94	1.19	1.36	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	509.51	3.10	1.06	1.24	0.80	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	350.04	7.08	0.73	0.21	0.94	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	334.21	3.59	0.51	0.34	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	352.65	2.21	3.10	1.88	1.44	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	442.44	2.41	0.92	1.00	1.00	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	441.85	3.27	0.00	0.00	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	288.21	2.89	3.09	0.83	1.44	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	409.41	2.88	2.77	1.27	1.50	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	290.84	1.17	2.33	1.50	1.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	262.75	3.09	1.54	1.10	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	380.66	2.34	3.94	1.84	1.35	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	270.69	2.76	2.43	0.97	0.97	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	293.13	1.60	2.57	3.85	2.25	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	348.13	2.27	3.22	1.42	1.61	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	232.52	1.27	1.27	0.95	0.63	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	238.10	3.65	4.26	2.74	3.95	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	318.32	2.93	2.82	1.78	1.78	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	253.81	0.88	2.63	0.88	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	279.15	3.37	3.37	2.24	1.96	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	297.39	1.48	1.20	0.83	0.65	2.04
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	208.31	2.67	2.67	1.60	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	257.66	2.30	2.30	1.53	1.22	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	275.27	1.94	2.85	0.91	0.78	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	245.86	1.90	2.98	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	277.08	3.50	2.58	1.29	1.84	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	307.91	3.95	3.95	0.66	1.54	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	296.53	0.99	0.99	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	294.96	2.90	1.71	0.79	1.85	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	269.95	2.62	1.41	1.21	1.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	501.20	3.81	0.25	1.02	2.29	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	504.02	2.99	1.00	0.60	2.39	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	426.33	4.47	4.78	1.69	2.62	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	512.28	2.25	4.09	1.43	1.43	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	233.76	2.50	0.31	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	211.63	0.57	1.41	1.41	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	243.06	7.38	1.84	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	240.06	9.90	7.42	0.00	2.47	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	295.14	6.58	4.25	1.16	1.16	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	356.19	8.02	3.21	3.21	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	288.65	10.43	6.96	8.69	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	301.39	5.86	1.95	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	312.15	5.35	6.59	1.65	2.88	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	253.25	26.66	33.32	0.00	6.66	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	302.86	5.59	3.08	1.40	0.56	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	296.77	10.13	3.27	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	251.65	15.10	8.39	8.39	1.68	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	339.06	5.73	2.54	1.27	1.27	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	291.43	9.51	4.42	1.02	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	248.49	4.18	4.18	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	350.49	5.73	4.58	1.15	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	251.59	8.88	2.37	0.89	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	206.69	11.86	6.78	6.78	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	316.45	4.56	7.46	2.07	4.14	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	268.10	6.90	2.99	0.69	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	194.93	0.00	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	297.53	8.07	3.84	3.46	0.77	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	283.92	7.50	4.56	0.33	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	203.33	4.01	2.01	0.00	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	390.28	6.55	5.78	2.31	2.70	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	360.83	8.90	2.05	2.05	1.37	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	323.02	17.39	14.91	7.45	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	319.91	8.49	5.19	1.89	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	351.23	8.45	8.45	1.81	1.81	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	284.86	5.09	3.05	1.53	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	319.87	6.38	3.59	1.60	2.39	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	324.63	8.39	2.96	4.44	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	352.95	17.71	8.26	7.08	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	368.74	9.34	6.42	0.00	0.58	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	313.80	7.90	4.39	1.76	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	285.67	16.11	4.24	3.39	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	291.89	11.34	3.58	0.60	0.60	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	282.90	9.70	2.91	1.94	1.94	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	133.53	1.14	1.14	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	177.97	9.15	2.08	0.83	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	47.23	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	184.59	3.17	2.85	1.27	0.95	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	167.10	3.76	2.92	0.42	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	244.50	3.13	3.13	1.74	0.93	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	338.28	1.18	4.90	1.18	1.35	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	284.83	1.82	2.28	0.68	1.59	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	254.58	2.62	3.39	1.64	1.31	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	298.51	2.15	2.58	0.86	0.64	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	274.05	0.86	2.80	0.86	0.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	218.81	3.24	3.99	1.12	1.00	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	251.83	1.89	2.57	1.37	0.69	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	238.36	1.28	2.56	1.28	0.00	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	596.56	1.12	6.16	1.12	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	290.84	0.87	0.87	0.00	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	761.42	7.93	23.79	5.29	7.93	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	179.18	0.71	1.06	0.35	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	175.09	0.00	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	181.13	1.75	3.67	0.87	0.87	0.70
Hepatocyte, donor1	11523-119I2	262.70	6.05	6.05	2.42	0.00	2.42
Hepatocyte, donor2	11603-120I1	297.35	4.31	4.31	0.00	3.23	3.23
Hepatocyte, donor3	11684-122I1	412.91	9.82	9.20	8.59	2.45	6.75
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.18	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	300.97	0.70	1.05	1.22	0.52	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	335.61	1.65	1.51	0.14	1.23	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	1023.99	13.46	3.51	2.77	2.61	1.31
Keratinocyte - epidermal, donor2	11349-117G8	242.45	1.17	2.93	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	346.35	5.02	3.12	1.23	1.23	1.51
Keratinocyte - oral, donor1	11251-116E9	736.39	3.06	3.06	1.48	1.59	0.68
Keratocytes, donor1	11527-119I6	201.83	0.00	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	86.71	0.00	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	212.81	1.98	3.56	1.78	0.79	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	479.15	0.00	0.00	2.20	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	296.65	3.24	6.47	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	457.29	1.04	1.15	0.46	0.46	0.46
Lens Epithelial Cells, donor3	11690-122I7	537.14	0.81	1.82	1.72	1.11	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	574.74	8.42	4.03	1.19	2.96	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	406.61	8.09	8.37	2.23	2.23	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	664.75	22.82	14.01	4.25	4.72	4.25
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	461.36	11.29	4.30	1.08	1.61	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	392.38	12.29	5.99	3.15	5.36	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	416.49	10.24	5.50	2.91	2.59	2.80
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	547.87	11.08	3.69	2.87	2.05	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	317.29	6.57	2.53	1.01	1.01	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	446.32	17.73	8.30	3.80	2.25	4.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	517.75	9.89	4.35	2.37	2.37	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	470.94	10.08	6.01	3.68	2.91	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	276.43	6.30	3.89	2.78	2.04	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	495.81	10.80	7.32	1.74	3.48	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	419.56	9.06	5.01	1.91	3.58	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	439.79	11.13	7.14	3.57	3.30	3.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	589.12	10.47	7.39	3.08	0.92	4.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	278.39	5.30	3.74	0.62	2.49	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	485.11	10.06	5.49	3.11	1.83	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	517.03	11.52	9.87	1.97	4.94	3.62
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	332.12	5.56	5.27	2.93	1.46	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	400.03	5.97	3.24	2.74	1.99	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	504.85	12.61	6.79	3.88	3.39	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	448.38	12.12	5.12	2.15	1.35	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	531.34	9.69	4.84	2.12	3.03	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	472.79	12.96	2.59	0.52	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	481.39	10.05	5.44	2.72	2.51	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	482.09	10.83	9.17	3.76	4.06	3.16
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	550.99	9.63	4.82	5.50	3.44	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	418.82	8.65	4.14	1.32	1.32	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	446.17	7.42	8.06	3.29	2.86	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	512.68	16.96	6.78	1.45	2.42	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	426.39	8.60	5.62	1.65	2.98	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	463.97	17.34	9.66	2.60	3.22	2.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	685.26	12.22	7.77	1.48	2.22	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	444.75	6.18	5.68	1.73	0.74	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	388.28	9.90	7.15	1.51	2.89	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	610.79	13.83	6.43	1.61	2.89	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	533.49	10.04	3.65	2.13	1.83	2.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	559.86	12.04	6.86	3.64	3.92	3.64
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	492.45	9.24	8.89	1.42	2.49	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	400.91	10.18	4.85	2.42	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	383.73	6.54	6.38	2.18	1.71	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	471.62	7.16	7.52	2.15	2.86	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	469.10	4.57	2.29	2.94	1.63	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	383.98	12.71	4.24	2.59	3.30	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	591.41	8.04	3.09	1.73	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	344.49	4.87	5.12	1.02	2.05	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	436.79	5.37	9.25	3.28	2.69	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	135.96	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	121.21	0.77	2.30	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	90.55	0.74	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	102.82	1.69	2.96	1.27	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	73.15	0.70	2.11	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	83.12	0.93	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	107.69	0.52	4.12	1.03	0.52	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	72.56	4.76	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	87.99	1.58	0.45	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	125.06	5.23	3.20	1.74	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	110.29	1.80	3.15	0.90	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	116.11	0.68	0.68	0.41	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	106.30	3.08	0.00	0.00	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	111.50	2.12	0.71	0.35	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	91.28	2.67	0.00	0.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	104.93	2.55	2.04	0.51	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	110.19	2.67	0.80	0.00	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	126.40	2.08	2.08	0.57	0.38	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	89.58	1.84	0.61	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	114.16	3.26	1.63	1.63	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	130.99	2.29	2.71	0.42	1.25	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	131.44	2.24	2.52	0.84	1.68	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	97.88	2.06	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	126.28	3.77	6.68	1.16	0.87	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	121.07	0.90	2.39	0.60	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	122.82	1.66	1.66	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	122.66	2.12	1.41	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	106.95	1.84	1.48	0.74	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	67.93	1.15	1.15	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	113.97	0.38	1.15	0.38	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	92.85	1.70	4.53	1.13	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	81.23	0.00	1.64	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	98.96	2.26	2.26	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	117.06	2.87	2.87	0.72	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	118.76	1.49	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	126.71	1.49	1.49	0.37	1.86	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	123.62	2.58	2.58	0.43	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	119.03	1.71	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	120.61	5.00	2.33	1.33	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	104.37	2.41	1.81	1.21	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	85.32	1.42	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	102.43	2.06	1.72	1.03	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	103.06	0.54	0.54	0.00	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	74.74	1.35	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	119.27	4.07	3.33	0.74	1.85	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	116.29	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	86.73	1.06	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	102.44	2.80	3.20	0.80	1.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	95.22	1.45	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	80.48	0.77	0.77	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	93.23	3.45	1.48	1.48	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	75.27	2.82	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	72.91	0.00	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	95.53	0.90	1.35	0.00	2.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	80.89	0.00	3.44	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	99.76	1.78	1.78	0.89	1.78	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	115.74	1.17	3.52	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	95.66	1.32	1.32	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	92.37	1.56	1.04	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	129.96	3.06	3.94	0.88	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	103.99	1.68	3.35	0.56	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	94.07	2.21	1.32	2.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	93.34	0.77	1.93	0.77	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	95.19	1.52	0.51	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	104.29	2.88	0.96	0.48	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	94.62	2.78	3.18	0.00	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	98.43	1.22	0.00	1.82	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	75.40	0.69	0.69	0.69	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	78.28	1.52	1.14	1.52	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	101.73	1.03	1.55	1.03	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	78.00	1.21	0.60	0.00	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	110.60	2.54	0.63	0.00	1.27	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	83.16	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	63.21	2.30	1.15	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	99.25	1.03	1.54	0.51	1.54	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	94.08	0.71	1.41	0.71	0.00	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	78.88	0.00	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	82.79	1.25	1.66	0.83	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	105.71	4.70	3.13	0.00	3.92	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	87.68	0.42	0.42	0.42	2.09	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	96.18	0.93	0.93	0.00	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	74.93	0.00	0.67	0.00	0.67	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	75.38	1.60	1.60	0.00	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	99.81	1.21	2.42	1.21	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	67.91	1.84	0.92	0.00	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	101.36	2.67	1.78	1.78	0.89	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	92.32	1.14	2.28	1.71	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	75.92	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	78.25	2.19	1.09	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	81.07	1.34	0.89	1.34	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	104.24	0.78	0.52	0.26	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	90.85	1.99	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	106.01	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	141.31	0.46	0.23	0.23	0.68	0.68
Macrophage - monocyte derived, donor2	11313-117C8	99.09	0.18	0.37	0.00	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	144.71	0.66	1.57	0.52	0.79	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	553.32	1.06	0.00	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	1755.49	8.71	10.77	4.91	4.12	7.76
Mallassez-derived cells, donor3	11930-125I4	605.29	3.75	4.17	1.67	1.11	1.81
Mammary Epithelial Cell, donor1	11273-116H4	691.33	11.16	3.09	1.40	1.69	1.10
Mammary Epithelial Cell, donor2	11350-117G9	608.92	7.82	3.47	2.03	2.32	2.90
Mammary Epithelial Cell, donor3	11422-118F9	291.08	0.50	3.74	1.25	1.50	0.00
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	16.34	0.00	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	15.98	0.00	0.00	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	23.22	0.00	0.35	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.22	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.58	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.11	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.67	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	455.10	2.79	1.49	1.19	0.40	0.30
Melanocyte - dark, donor2	11582-120F7	270.29	3.81	3.46	2.08	0.35	1.38
Melanocyte - dark, donor3	11663-122F7	166.25	0.87	0.51	0.29	0.29	0.07
Melanocyte - light, donor1	11274-116H5	122.71	0.71	0.47	0.47	0.47	0.00
Melanocyte - light, donor2	11351-117H1	91.45	0.68	0.00	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	112.74	0.87	0.87	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	173.68	1.25	1.77	1.35	0.52	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	184.76	1.34	1.34	0.54	0.81	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	204.91	1.34	1.61	0.80	0.27	0.27
Meningeal Cells, donor1	11493-119E8	341.04	1.24	0.50	0.25	0.00	0.12
Meningeal Cells, donor2	11573-120E7	319.55	2.64	1.76	2.20	0.44	0.88
Meningeal Cells, donor3	11654-122E7	253.31	1.79	1.06	0.57	0.33	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	175.94	1.14	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	636.80	11.87	1.61	1.91	1.51	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	88.05	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	51.02	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	162.90	6.46	2.15	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	407.44	5.72	1.91	0.85	0.85	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	268.41	3.52	2.01	1.51	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	105.70	0.66	0.44	0.22	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	93.52	0.73	1.46	0.00	2.92	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	82.25	0.41	1.02	0.61	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	291.56	2.35	1.11	0.42	0.28	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	151.66	0.00	1.49	0.37	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	403.01	3.16	2.50	0.79	0.66	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	152.52	1.19	1.48	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	133.13	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	144.73	0.00	1.92	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	224.01	0.35	0.71	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	344.62	1.56	3.13	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	174.89	5.08	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	404.66	7.16	1.06	0.53	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	614.07	3.00	3.00	1.00	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	235.51	3.83	2.46	1.30	2.02	1.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	105.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.50	0.49	0.25	0.25	0.99	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	113.66	0.59	1.47	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	221.25	0.00	3.46	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	95.15	0.31	0.62	0.00	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	98.74	0.21	1.04	0.41	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	132.01	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	120.88	0.75	1.50	0.25	0.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	134.52	0.00	0.47	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	214.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	101.20	0.41	0.81	0.61	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	119.58	0.40	0.40	0.40	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	153.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	62.83	0.00	1.77	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	106.38	1.14	1.52	0.00	0.76	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	127.64	0.00	0.00	3.95	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	67.91	1.06	0.64	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	90.24	0.00	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	98.66	0.60	1.19	0.89	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	120.72	0.00	0.00	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	84.55	1.51	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	105.76	1.19	1.19	0.48	1.66	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	116.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	94.17	1.61	1.15	0.46	0.46	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	119.05	0.21	1.05	0.84	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	88.26	0.00	0.00	0.20	0.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	89.46	0.64	0.43	0.64	0.64	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	108.03	0.22	0.67	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	268.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	103.16	1.10	0.22	0.22	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	84.66	0.00	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	135.87	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	112.79	1.09	1.09	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	123.81	0.59	0.00	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	141.74	0.00	3.27	3.27	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	76.89	2.88	0.00	0.00	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	144.08	1.20	3.20	0.40	0.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	115.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	103.12	2.00	0.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	103.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	144.51	1.75	0.88	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	141.27	0.00	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	122.31	0.64	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	150.73	0.74	1.24	1.24	0.25	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	114.13	0.70	2.09	0.70	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	145.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	152.48	3.42	3.08	0.68	1.03	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	119.47	0.00	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	132.45	0.00	0.00	0.36	1.07	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	132.98	1.68	1.96	0.84	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	151.70	0.00	0.42	1.25	0.42	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	105.48	0.00	0.58	0.58	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	133.94	1.81	0.60	0.60	0.00	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	155.69	1.25	0.42	1.67	0.00	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	180.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	125.60	0.92	2.77	1.85	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	150.82	0.00	0.00	0.57	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	129.61	0.14	0.55	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	136.57	1.55	0.52	1.04	0.26	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	157.01	0.43	1.29	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	93.37	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	145.99	0.80	1.07	0.00	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	155.65	0.60	1.80	0.60	0.00	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	95.49	0.14	0.71	0.28	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	153.52	0.32	2.23	0.64	0.64	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	145.28	0.44	0.66	0.88	0.44	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	93.28	0.00	1.52	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	137.22	1.42	1.99	0.57	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	137.65	0.74	0.98	1.72	0.49	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	91.89	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	130.55	1.47	0.59	0.88	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	154.25	2.31	1.44	0.58	0.58	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	164.03	0.41	1.24	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	139.96	0.89	1.19	0.00	0.30	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	76.23	2.63	0.99	0.66	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	3.16	1.05	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	74.53	1.38	0.79	0.40	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	64.26	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	66.47	2.25	1.13	0.00	0.38	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	57.80	0.80	0.00	0.27	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	64.35	0.11	0.00	0.23	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	51.57	3.68	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	78.05	1.10	1.10	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	59.11	4.67	1.56	0.00	4.67	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	49.17	0.53	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	65.65	1.01	2.02	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.53	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	234.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	66.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	44.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	83.07	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	976.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	668.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	285.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	263.53	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	259.38	5.17	1.72	1.29	1.08	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	248.76	4.18	0.00	2.09	2.61	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	114.14	1.33	1.33	1.33	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	104.34	0.42	0.42	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	135.76	1.90	0.38	0.95	0.38	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	276.08	1.60	3.19	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	95.19	1.36	1.36	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	396.93	7.35	5.51	9.19	7.35	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	133.51	2.51	1.26	0.00	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	132.03	1.39	0.70	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	146.46	0.27	1.62	0.54	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	260.27	1.26	1.05	1.26	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2048.79	11.13	22.27	44.54	11.13	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	133.02	2.48	2.48	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	207.87	4.06	1.62	0.81	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	134.42	2.04	1.13	0.45	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	206.09	2.12	0.65	0.82	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	354.12	5.83	6.56	1.82	2.19	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	158.07	5.30	0.53	3.18	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	147.07	0.00	0.60	1.80	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	239.24	5.91	2.95	1.64	1.97	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	154.17	0.33	1.14	1.30	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	450.83	4.41	6.70	2.65	2.29	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	168.78	2.81	4.22	2.81	2.81	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	208.25	1.84	0.92	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	282.46	3.21	2.25	1.61	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	198.31	15.18	3.79	2.76	2.07	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	922.88	2.53	15.17	17.70	12.64	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	449.13	3.56	4.01	1.78	2.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	203.23	4.66	3.39	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	201.27	4.98	0.95	0.95	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	239.52	2.58	3.00	2.15	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2518.74	9.03	54.17	18.06	45.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	229.26	2.00	1.33	0.67	2.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	401.72	3.16	2.71	1.35	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	169.04	1.98	2.38	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	155.08	2.79	3.71	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	277.35	3.78	1.89	1.51	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	134.92	1.30	1.63	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	174.31	0.87	0.00	0.44	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	440.53	3.62	1.81	2.71	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	164.04	2.65	2.65	0.88	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	180.17	3.32	1.99	2.66	3.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	226.69	0.99	1.49	0.99	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	119.82	0.38	0.77	1.15	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	537.45	7.56	4.84	1.51	0.91	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	399.83	3.98	4.20	1.33	1.99	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	153.83	4.74	0.68	1.36	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	700.01	15.33	20.44	25.55	5.11	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	195.10	1.22	1.83	3.05	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	142.58	1.57	0.63	0.63	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	191.28	0.91	2.12	0.30	1.82	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	200.16	3.96	3.16	6.33	3.96	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	182.52	10.20	0.00	4.53	2.27	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	718.22	20.23	5.06	20.23	20.23	25.29
Myoblast, donor1	11241-116D8	254.30	3.73	1.49	0.87	0.99	0.12
Myoblast, donor2	11322-117D8	210.78	3.07	4.99	2.11	2.30	1.15
Myoblast, donor3	11398-118D3	266.03	2.69	1.85	0.50	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	27.98	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	20.81	0.00	0.60	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	20.43	0.00	0.37	0.37	0.37	0.00
Neural stem cells, donor1	11275-116H6	544.41	9.44	0.00	1.45	0.00	0.73
Neural stem cells, donor2	11352-117H2	812.62	5.78	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	394.85	6.83	3.41	2.28	1.14	2.28
Neurons, donor2	11574-120E8	441.43	3.96	0.44	1.54	1.98	0.88
Neurons, donor3	11655-122E8	248.29	8.22	7.40	2.47	3.29	0.82
Neutrophils, donor1	11233-116C9	23.20	0.00	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	58.03	0.61	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	322.72	1.78	2.14	0.95	0.71	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	167.69	1.95	1.30	1.63	2.28	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	197.34	1.60	3.01	0.60	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	145.22	2.89	2.06	0.55	0.69	0.69
Olfactory epithelial cells, donor2	11934-125I8	117.10	2.32	5.21	1.01	0.87	0.29
Olfactory epithelial cells, donor3	11935-125I9	138.70	2.95	2.27	0.34	0.79	0.34
Olfactory epithelial cells, donor4	11936-126A1	253.91	3.70	2.63	1.07	2.14	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	307.53	4.21	1.20	0.00	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	101.24	0.00	0.85	0.21	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	91.45	0.00	2.29	0.00	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	112.97	0.00	1.24	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	94.59	0.78	0.59	0.59	0.00	0.20
Osteoblast, donor2	11354-117H4	174.88	4.21	1.40	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	88.69	0.00	0.36	0.53	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	439.96	7.50	2.27	1.01	1.10	0.76
Pericytes, donor1	11491-119E6	108.60	0.45	0.45	0.22	0.00	0.11
Pericytes, donor2	11571-120E5	130.84	0.68	0.91	0.00	0.00	0.45
Pericytes, donor3	11652-122E5	166.83	1.63	1.02	0.61	0.61	0.41
Perineurial Cells, donor1	11499-119F5	327.65	3.96	1.13	0.45	0.90	0.34
Perineurial Cells, donor2	11579-120F4	355.81	1.66	1.29	0.55	0.92	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	137.06	0.00	0.64	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	69.54	0.73	1.71	0.24	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	62.25	0.13	0.91	0.26	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	78.69	1.67	0.48	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	170.77	6.65	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	192.01	1.37	1.18	0.20	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	108.54	2.85	1.27	2.22	0.63	0.95
Preadipocyte - breast, donor1	11467-119B9	247.05	5.44	1.50	0.00	0.75	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	261.58	5.61	0.39	0.00	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	247.21	6.08	4.50	1.13	1.35	1.13
Preadipocyte - omental, donor1	11468-119C1	254.46	6.39	1.28	0.75	0.85	0.32
Preadipocyte - omental, donor2	11329-117E6	310.77	3.93	0.44	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	250.54	6.88	2.72	1.15	1.72	2.15
Preadipocyte - perirenal, donor1	11469-119C2	100.40	3.94	1.97	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	106.88	0.61	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	185.05	4.60	3.72	0.53	0.89	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	217.96	3.07	1.36	0.85	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	261.28	4.47	0.65	0.47	0.65	0.37
Preadipocyte - visceral, donor2	11357-117H7	335.47	5.52	3.68	2.76	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	164.26	3.76	1.57	0.52	0.52	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	315.88	2.56	2.72	0.60	1.36	0.91
Prostate Epithelial Cells, donor2	11331-117E8	1070.71	14.90	12.05	3.79	6.50	4.47
Prostate Epithelial Cells, donor3	11404-118D9	301.35	4.84	4.16	2.27	2.51	2.02
Prostate Stromal Cells, donor1	11254-116F3	305.82	3.99	2.05	0.68	0.57	0.46
Prostate Stromal Cells, donor2	11332-117E9	235.96	7.89	6.10	2.15	2.33	2.15
Prostate Stromal Cells, donor3	11405-118E1	260.06	4.59	3.86	0.94	1.56	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	278.48	1.09	0.73	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	683.21	4.16	3.47	1.39	2.01	1.18
Renal Epithelial Cells, donor1	11517-119H5	106.01	0.00	0.00	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	214.11	0.00	2.13	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	823.31	4.34	3.49	1.16	1.38	1.69
Renal Glomerular Endothelial Cells, donor1	11514-119H2	386.72	0.68	4.77	0.68	1.36	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	548.76	2.16	6.60	2.29	3.91	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	442.25	5.11	9.55	9.77	7.99	5.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	300.11	1.33	0.67	1.33	0.67	2.66
Renal Mesangial Cells, donor1	11518-119H6	195.22	0.88	0.44	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	256.44	0.63	0.00	1.88	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	111.24	0.83	1.39	0.83	0.83	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	322.38	2.42	1.34	0.81	0.81	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	191.45	1.27	2.11	0.00	2.11	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	188.80	0.96	0.39	0.39	0.77	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	449.85	2.07	1.04	1.04	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	716.86	2.84	3.98	2.27	3.41	3.13
Retinal Pigment Epithelial Cells, donor2	11608-120I6	90.56	3.09	1.03	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	411.74	1.51	0.75	0.50	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	508.75	1.07	2.27	1.60	1.07	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	469.04	8.93	4.47	0.89	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	251.52	5.50	3.30	3.30	2.75	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	410.10	2.32	2.32	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	323.89	1.95	1.43	1.17	0.91	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	268.03	2.18	4.37	1.39	2.18	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	403.10	2.23	1.45	0.45	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	382.30	5.71	3.85	1.61	1.98	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	275.75	2.68	6.06	1.40	1.63	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	375.36	3.93	7.17	2.31	2.31	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	281.35	2.19	2.74	1.10	1.23	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	253.38	1.97	4.69	2.12	2.27	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	367.88	2.69	1.08	0.72	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	284.04	4.88	2.58	1.00	0.86	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	270.86	3.97	3.54	1.29	0.86	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	299.16	3.98	2.88	0.89	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	269.56	2.68	1.72	2.49	1.53	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	266.54	1.30	2.89	1.49	0.93	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	431.43	1.69	1.69	1.13	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	264.88	1.59	1.59	0.80	1.46	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	276.64	1.65	4.48	1.65	1.36	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	309.54	6.11	2.67	1.15	1.34	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	251.71	2.35	2.24	0.85	1.17	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	253.12	7.57	5.61	2.24	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	312.92	3.08	4.61	1.20	1.03	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	241.22	1.09	1.82	1.09	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	253.60	3.92	2.82	1.23	1.72	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	330.56	0.94	2.42	2.15	0.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	295.55	4.25	2.12	0.47	1.18	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	272.22	3.57	3.57	1.59	2.38	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	305.40	2.57	3.51	0.94	0.94	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	268.94	3.32	3.11	1.24	0.21	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	270.32	2.88	8.85	2.88	1.77	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	289.10	2.09	3.34	1.25	1.04	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	280.74	4.58	1.75	0.94	1.08	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	270.77	1.36	3.07	1.87	1.53	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	298.06	2.70	5.01	0.77	1.74	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	286.10	4.30	2.24	1.38	0.52	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	266.66	1.78	2.61	2.06	1.65	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	299.44	3.12	6.57	1.31	1.48	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	278.14	3.07	2.73	0.68	1.36	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	306.12	3.70	2.52	1.04	1.04	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	274.55	1.60	1.07	0.00	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	335.43	1.66	2.35	1.24	0.97	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	326.91	3.81	3.10	1.67	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	401.27	1.61	2.42	1.41	0.81	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	322.55	4.33	2.45	1.41	0.66	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	389.54	11.88	2.10	1.75	2.10	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	363.26	2.12	4.53	0.60	1.51	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	355.29	6.73	1.59	0.61	1.10	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	731.55	4.08	2.77	1.46	1.75	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	423.47	5.48	4.26	1.22	2.43	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	352.64	3.92	2.11	0.60	1.51	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	554.39	10.86	6.11	1.81	1.81	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	566.43	4.19	4.49	1.80	1.50	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	590.49	5.08	6.73	1.77	1.65	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	547.91	1.07	7.90	1.92	1.28	6.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	472.97	2.40	2.40	1.20	1.80	3.61
Schwann Cells, donor1	11498-119F4	102.87	0.38	0.56	0.19	0.94	0.19
Schwann Cells, donor2	11578-120F3	238.17	10.21	10.21	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	248.66	2.63	4.60	1.97	1.53	1.97
Sebocyte, donor1	11220-116B5	1064.32	2.74	1.10	1.64	0.00	1.10
Sebocyte, donor2	11301-117B5	567.55	8.27	6.89	1.84	5.51	2.76
Sebocyte, donor3	11378-118B1	198.69	0.62	1.86	0.62	0.82	0.62
Sertoli Cells, donor1	11255-116F4	362.79	8.28	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	234.42	8.47	5.65	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	295.17	5.81	0.97	0.44	0.53	0.53
Skeletal Muscle Cells, donor2	11358-117H8	132.28	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	102.83	0.00	0.84	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	144.68	0.94	2.67	0.79	0.63	0.47
Skeletal Muscle Cells, donor5	11455-119A6	153.55	2.68	2.53	0.45	0.74	0.45
Skeletal Muscle Cells, donor6	11459-119B1	159.75	1.54	2.00	0.62	1.39	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	324.84	1.76	2.14	1.26	0.76	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	225.59	2.43	4.14	0.71	1.00	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	205.66	1.59	2.08	0.60	0.69	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	337.93	4.30	1.35	0.59	0.34	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	74.55	0.00	0.72	0.00	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	98.93	0.00	2.06	0.28	0.69	0.55
Skin - palm, donor1	10286-104F7	308.90	2.69	5.37	5.37	5.37	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	409.84	2.45	4.61	2.74	3.17	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	937.30	4.91	2.45	0.00	0.82	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	229.92	1.69	0.91	0.65	0.91	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	1192.13	12.09	9.87	3.61	4.31	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	639.99	4.36	10.83	4.78	5.20	2.39
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1487.52	14.38	5.92	6.34	2.96	4.23
Small Airway Epithelial Cells, donor3	11406-118E2	673.43	2.25	6.30	3.75	3.37	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.68	1.23	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1060.07	18.45	4.22	3.11	1.56	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	218.08	1.18	0.00	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	329.50	2.21	1.10	0.66	0.22	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	174.05	1.18	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	258.04	2.32	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	157.12	4.00	8.01	5.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	307.68	1.46	1.33	1.06	0.93	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	130.55	7.76	2.22	0.89	1.33	2.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	104.60	0.51	0.38	0.38	0.51	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	241.59	0.98	0.98	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	345.53	3.84	0.59	0.59	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	247.00	1.28	1.14	0.43	1.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	58.07	0.16	0.00	0.16	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	210.06	2.44	2.74	4.57	2.13	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	153.05	0.00	0.25	0.25	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	80.59	0.00	0.48	0.48	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	294.36	2.51	1.47	0.74	1.03	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	219.54	1.94	2.80	1.08	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	219.68	1.57	1.78	0.94	0.84	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	174.63	0.77	0.46	0.46	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	120.72	0.00	0.00	1.08	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	206.51	2.39	3.89	0.90	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	93.54	0.00	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	398.22	2.43	2.75	0.47	1.26	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	279.18	7.45	1.51	1.01	0.40	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	443.73	8.19	6.83	2.28	1.59	2.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	137.07	0.00	1.81	0.60	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	171.41	1.59	0.00	0.79	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	199.47	3.99	0.67	0.53	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	451.92	11.39	5.89	2.13	2.13	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	213.33	2.54	0.51	0.25	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	271.99	1.81	0.75	1.06	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	192.04	1.50	1.50	0.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	934.27	2.58	2.58	1.29	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	172.08	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	274.15	4.04	2.52	0.00	1.01	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	172.99	3.13	5.01	1.57	1.57	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	99.12	1.18	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	233.68	0.17	0.25	0.17	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	257.87	1.87	3.27	1.87	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	192.13	0.43	1.01	0.58	0.14	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	109.89	0.76	1.53	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	98.15	0.00	1.32	0.75	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	267.05	1.68	0.56	0.84	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	350.07	2.26	1.59	0.50	0.50	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	60.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	172.49	0.00	0.49	0.49	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	241.94	10.83	1.10	0.22	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	124.05	4.10	1.76	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	347.71	3.89	2.53	0.58	0.78	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	254.67	9.26	2.64	1.85	0.79	3.44
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	221.31	9.67	6.32	1.49	0.37	4.09
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	436.24	10.42	3.23	1.08	2.52	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	286.74	3.41	1.42	1.14	0.85	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	146.13	2.36	1.97	0.00	1.58	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	293.57	7.36	3.81	2.03	1.78	3.56
Smooth muscle cells - airway, control, donor2	11967-126D5	317.06	11.18	4.39	1.60	2.00	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	282.57	16.30	2.93	0.84	1.67	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	332.77	9.63	2.75	2.75	1.38	1.83
Synoviocyte, donor1	11291-117A4	139.87	4.71	0.50	0.50	0.17	0.67
Synoviocyte, donor2	11368-117I9	130.91	3.35	2.51	0.50	1.17	0.67
Synoviocyte, donor3	11440-118H9	117.07	10.05	3.80	0.89	1.56	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	130.78	1.07	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	82.43	0.46	0.93	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	330.11	0.86	1.43	0.86	1.00	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	125.63	0.00	1.55	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	146.03	0.00	3.44	0.57	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	510.80	1.72	2.83	1.60	1.72	0.62
Urethra, donor2	10319-105A4	289.55	5.40	1.80	1.80	1.80	1.80
Urothelial Cells, donor1	11520-119H8	276.55	0.53	1.86	0.80	0.27	0.27
Urothelial Cells, donor2	11600-120H7	370.52	2.80	3.20	0.00	0.80	1.20
Urothelial Cells, donor3	11681-122H7	286.74	0.92	1.38	0.92	0.23	0.23
Urothelial cells, donor0	11216-116B1	969.59	4.90	5.57	1.78	1.56	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	181.52	2.67	0.89	0.89	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	177.27	4.29	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	102.68	1.37	2.05	0.68	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	94.00	0.00	1.38	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	85.41	0.58	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	140.57	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	164.28	0.92	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	116.85	1.83	3.65	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	156.30	2.47	1.23	0.74	1.48	0.99
Wilms' tumor cell line:HFWT	10597-108E3	764.75	1.76	4.40	8.80	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	280.71	3.07	1.96	3.07	0.56	1.12
achilles tendon, donor2	10292-104G4	165.32	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	96.88	2.55	0.51	0.25	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	139.30	0.00	0.46	0.70	0.23	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.70	0.82	0.27	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	206.60	2.53	3.09	1.12	1.41	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	108.49	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	161.97	0.82	1.63	0.54	0.82	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	412.88	2.20	1.76	3.08	0.88	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	475.33	5.31	3.68	2.04	4.08	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	177.45	1.16	2.72	2.72	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	233.68	2.94	3.13	1.66	0.55	1.84
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	319.84	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	185.44	3.02	3.49	1.16	0.93	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	139.29	1.55	2.59	0.78	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	139.98	1.46	3.51	0.88	1.46	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.42	0.46	0.93	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	116.03	0.31	1.23	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	163.86	1.28	0.00	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	199.87	0.91	0.00	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	199.30	0.72	0.00	0.24	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.51	0.00	0.45	0.67	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	123.92	1.13	0.38	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	151.34	0.87	1.31	0.44	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	313.92	2.59	1.88	1.65	1.88	0.24
adipose tissue, adult, pool1	10010-101C1	324.51	0.47	3.57	1.24	0.93	0.00
adipose, donor1	10184-103D4	358.88	8.80	9.38	3.52	2.35	1.76
adipose, donor2	10185-103D5	231.15	5.27	2.03	0.81	1.62	0.00
adipose, donor3	10186-103D6	268.48	7.08	4.08	2.18	0.82	1.63
adipose, donor4	10187-103D7	415.17	13.87	4.33	2.60	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	266.72	1.26	1.74	1.26	0.95	0.47
adrenal gland, adult, pool1	10081-102A9	240.09	3.64	7.28	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	293.34	2.14	2.86	1.43	2.14	0.71
amniotic membrane cells, donor1	12235-129G3	416.63	5.10	1.39	1.16	0.93	0.23
amniotic membrane cells, donor2	12236-129G4	377.32	4.73	1.69	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	500.23	7.07	4.71	3.24	2.06	1.47
amygdala - adult, donor10196	10167-103B5	837.17	8.30	7.11	11.86	2.37	3.56
amygdala, adult, donor10252	10151-102I7	714.55	11.96	8.92	16.02	6.29	4.46
amygdala, newborn, donor10223	10360-105E9	489.32	5.16	2.26	3.23	1.61	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	541.28	2.55	0.38	0.89	1.02	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.84	3.01	0.33	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	368.73	8.04	5.30	3.53	2.94	1.37
appendix, adult	10189-103D9	282.55	0.78	3.49	1.16	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	88.05	1.03	0.00	0.34	0.34	0.34
artery, adult	10190-103E1	229.62	5.43	2.72	2.72	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	362.89	3.62	1.16	0.58	0.87	0.14
b cell line:RPMI1788	10427-106D4	70.78	0.45	0.00	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	565.44	22.47	3.88	1.94	2.77	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	362.89	1.39	0.99	0.50	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	275.00	1.51	1.17	0.50	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	8.39	0.00	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	415.66	3.04	2.50	2.39	1.63	0.76
blood, adult, pool1	10053-101G8	84.16	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	286.88	11.99	0.00	0.86	0.86	0.00
bone marrow, adult	10192-103E3	313.12	8.10	12.15	3.37	3.37	1.35
brain, adult, donor1	10084-102B3	557.64	17.43	15.38	6.15	7.18	2.05
brain, adult, pool1	10012-101C3	868.93	9.58	7.13	8.91	5.01	2.23
brain, fetal, pool1	10085-102B4	507.57	10.69	8.01	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	171.13	2.31	3.96	1.32	1.32	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	296.20	0.50	0.37	0.75	0.37	0.25
breast, adult, donor1	10080-102A8	249.39	1.26	0.00	0.63	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	207.96	4.45	2.79	1.02	0.76	2.03
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	381.58	2.47	3.71	3.40	2.16	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	211.57	6.68	3.45	0.46	0.69	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	212.79	2.42	2.18	1.21	2.18	0.48
carcinoid cell line:NCI-H1770	10703-109H1	153.74	2.82	0.47	0.94	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	476.90	1.64	2.19	2.19	2.08	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	165.42	1.90	0.32	0.63	2.22	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	478.85	7.45	9.32	4.26	3.73	4.53
caudate nucleus - adult, donor10196	10177-103C6	750.66	9.21	2.30	4.61	5.76	5.76
caudate nucleus, adult, donor10252	10164-103B2	859.72	12.38	12.55	17.23	7.20	3.85
caudate nucleus, adult, donor10258	10379-105H1	849.72	9.17	6.11	7.64	4.58	4.58
caudate nucleus, newborn, donor10223	10354-105E3	676.80	2.56	4.03	0.73	1.46	0.37
cerebellum - adult, donor10196	10173-103C2	795.32	11.65	0.00	5.83	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	638.82	4.91	9.18	5.12	3.42	1.92
cerebellum, adult, pool1	10083-102B2	384.96	11.73	7.24	3.45	3.10	2.07
cerebellum, newborn, donor10223	10357-105E6	616.07	4.15	6.64	4.15	1.66	3.32
cerebral meninges, adult	10188-103D8	878.71	2.77	7.06	10.09	3.78	4.79
cerebrospinal fluid, donor2	10294-104G6	250.69	0.73	1.46	2.92	2.19	2.19
cervical cancer cell line:D98-AH2	10552-107I3	215.53	1.73	0.86	0.29	0.29	0.43
cervical cancer cell line:ME-180	10553-107I4	403.19	2.32	0.66	0.33	1.16	0.50
cervix, adult, pool1	10013-101C4	362.32	1.57	1.05	1.15	1.15	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	888.56	11.57	4.88	1.67	2.65	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	245.58	0.00	0.00	1.31	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	537.49	4.97	1.62	1.24	0.75	0.62
choriocarcinoma cell line:SCH	10785-110H2	236.94	3.70	2.22	1.72	1.23	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	488.11	1.90	4.74	2.13	0.71	1.90
chorionic membrane cells, donor1	12238-129G6	301.73	7.69	2.28	0.85	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	495.86	6.56	3.28	1.09	0.80	0.70
chorionic membrane cells, donor3	12240-129G8	381.89	12.09	5.49	3.30	3.30	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	11.11	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	176.73	2.31	1.34	1.15	0.77	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	168.89	0.78	0.52	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	328.47	10.97	7.09	4.11	1.37	1.37
clear cell carcinoma cell line:TEN	10636-108I6	152.34	3.12	0.52	0.17	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	223.68	0.92	0.73	0.37	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	89.70	0.76	0.00	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	346.30	7.14	5.95	3.57	2.38	2.38
colon, adult, pool1	10014-101C5	406.44	1.29	1.53	1.18	1.29	0.12
colon, fetal, donor1	10070-101I7	317.65	4.33	3.71	4.94	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	270.43	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	97.31	0.85	0.42	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	80.60	0.45	0.45	0.15	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	98.28	0.99	0.00	0.56	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	1301.98	3.98	5.97	2.43	2.65	0.88
cruciate ligament, donor2	10295-104G7	300.68	1.62	1.62	0.81	1.62	4.05
diaphragm, fetal, donor1	10069-101I6	148.47	4.01	2.41	0.80	1.61	0.00
diencephalon, adult	10193-103E4	884.84	12.72	12.72	6.48	6.00	9.36
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.23	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	506.47	0.00	0.77	0.77	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	703.39	12.28	3.85	1.20	4.81	1.69
ductus deferens, adult	10196-103E7	780.90	2.99	16.45	9.47	5.48	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	315.41	11.52	8.64	4.32	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	631.92	9.56	21.33	4.41	6.62	5.89
dura mater, adult, donor1	10041-101F5	658.39	1.73	2.81	1.24	1.16	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	194.31	1.33	0.89	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	318.54	3.58	1.00	0.43	0.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	310.16	0.62	0.62	0.62	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	358.71	3.63	5.15	1.51	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	272.32	0.62	1.85	1.85	2.47	0.93
embryonic pancreas cell line:2C6	10603-108E9	316.55	1.31	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	469.94	4.36	0.67	1.34	2.35	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1039.20	29.90	5.62	3.44	5.62	4.53
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	262.77	4.82	5.47	1.77	1.77	1.93
epidermoid carcinoma cell line:A431	10426-106D3	238.21	1.33	1.00	0.78	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	352.50	2.42	1.21	0.44	0.44	0.22
epididymis, adult	10197-103E8	456.93	2.09	4.40	3.56	3.14	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	319.87	8.34	3.90	1.24	1.42	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	169.88	0.39	1.97	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	206.93	4.06	3.54	0.79	1.31	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	208.16	2.36	2.85	0.79	0.98	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	200.87	4.26	3.70	1.68	1.23	0.45
esophagus, adult, pool1	10015-101C6	251.00	1.81	2.97	1.17	1.38	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1060.50	3.13	2.88	2.38	2.76	1.25
eye - muscle inferior rectus, donor1	10272-104E2	376.67	2.41	7.24	4.83	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	216.73	0.00	0.00	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	294.67	0.00	4.46	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	350.83	3.44	2.29	2.29	2.29	5.73
eye - vitreous humor, donor1	10268-104D7	169.06	1.46	2.91	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	471.86	4.83	6.61	3.56	3.81	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	257.99	3.97	2.05	1.54	1.03	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	263.30	2.37	1.90	1.66	1.66	0.95
frontal lobe, adult, pool1	10040-101F4	1350.31	3.66	3.85	3.47	2.91	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	152.53	5.70	0.60	1.80	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	464.68	3.38	0.82	1.10	0.64	0.09
gall bladder, adult	10198-103E9	519.32	2.17	7.24	1.45	2.90	2.17
gamma delta positive T cells, donor1	11937-126A2	15.57	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	38.47	0.37	0.00	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	568.59	8.24	16.90	4.65	5.07	6.13
gastric adenocarcinoma cell line:MKN45	10612-108F9	338.09	2.32	4.06	2.13	2.32	2.13
gastric cancer cell line:AZ521	10549-107H9	318.89	1.31	1.31	0.66	0.66	0.00
gastric cancer cell line:GSS	10560-108A2	427.41	2.75	1.83	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.71	0.00	0.23	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	154.33	2.98	0.57	0.23	0.80	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	530.73	2.94	0.70	0.42	0.84	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	131.19	0.75	1.50	1.00	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	383.58	5.81	2.22	1.48	1.16	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	356.71	3.65	1.40	2.39	1.26	0.42
glioblastoma cell line:T98G	10485-107A8	255.62	4.19	1.66	0.55	0.55	0.44
glioma cell line:GI-1	10413-106B8	285.26	2.34	0.29	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	694.65	5.10	5.10	3.64	3.64	3.64
globus pallidus, adult, donor10252	10161-103A8	846.76	10.01	12.20	8.54	4.64	1.22
globus pallidus, adult, donor10258	10367-105F7	776.34	16.43	8.22	12.32	4.11	8.22
globus pallidus, newborn, donor10223	10364-105F4	552.10	1.60	3.73	2.66	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	567.74	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	255.36	1.92	5.44	2.56	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	304.39	3.21	1.84	0.46	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	360.78	0.00	2.29	0.46	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	318.18	3.86	1.93	0.00	1.29	1.29
hIPS, biol_rep1	14380-156B6	346.39	1.44	0.00	0.00	1.44	2.87
hIPS, biol_rep2	14381-156B7	260.63	2.06	3.43	1.37	0.00	1.37
hIPS, biol_rep3	14382-156B8	904.84	4.41	5.52	8.83	5.52	4.41
hairy cell leukemia cell line:Mo	10712-109I1	5.17	0.29	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	465.79	3.89	6.88	2.39	5.08	1.20
heart - pulmonic valve, adult	10206-103F8	350.12	1.57	5.49	2.35	3.14	1.05
heart - tricuspid valve, adult	10207-103F9	423.81	1.67	4.16	4.16	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	309.76	8.37	9.59	4.29	3.26	1.43
heart, adult, diseased, donor1	10051-101G6	281.48	3.41	7.24	4.26	3.83	1.70
heart, adult, pool1	10016-101C7	362.44	0.23	0.92	1.84	1.38	0.69
heart, fetal, pool1	10046-101G1	567.62	1.64	2.57	1.75	1.23	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	368.69	2.78	1.54	2.47	1.54	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	92.76	0.00	1.19	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	131.49	1.88	1.22	0.55	0.44	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	133.03	1.94	2.06	1.09	0.85	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	138.54	0.61	1.21	0.81	0.61	0.30
hepatoma cell line:Li-7	10484-107A7	390.03	5.00	2.45	1.33	0.67	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.41	0.60	0.10	0.00	0.30	0.00
hippocampus - adult, donor10196	10169-103B7	732.46	8.52	1.89	13.25	2.84	5.68
hippocampus, adult, donor10252	10153-102I9	674.96	12.04	9.18	12.65	7.96	5.10
hippocampus, adult, donor10258	10374-105G5	1126.36	3.98	18.42	10.46	7.47	10.95
hippocampus, newborn, donor10223	10363-105F3	426.50	1.76	2.82	0.70	1.76	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	623.77	12.82	15.26	5.49	4.27	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	484.41	8.05	6.68	1.77	2.55	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	501.95	7.62	3.55	2.29	2.29	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	329.86	5.07	3.95	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	275.51	9.55	11.36	4.39	4.13	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	375.81	3.04	4.56	0.38	1.90	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	299.25	1.75	1.46	2.92	1.46	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	298.80	4.74	4.74	1.29	2.15	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	259.84	4.59	0.83	0.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	349.74	4.50	2.13	0.00	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	283.02	6.11	3.70	2.25	1.77	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	332.61	6.06	2.02	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	390.59	4.38	5.79	2.35	2.35	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	412.20	8.35	7.37	3.93	3.93	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	418.05	6.98	7.85	0.00	3.49	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	337.91	2.86	5.54	1.34	0.95	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	298.71	2.18	3.05	1.74	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	246.88	3.00	13.49	0.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	307.64	2.64	6.59	1.70	3.39	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	323.76	2.73	4.09	1.82	1.36	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	290.68	5.01	2.19	1.88	1.88	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	422.95	9.14	6.70	2.61	2.12	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	424.72	7.26	4.06	2.32	2.03	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	370.07	7.17	5.38	0.90	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	601.71	8.68	10.72	5.54	4.25	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	562.01	7.70	7.13	1.71	2.28	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	696.99	7.76	5.72	2.45	2.04	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	479.89	7.04	12.32	3.17	3.52	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	458.96	5.07	7.29	3.17	1.58	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	459.38	3.03	4.24	0.91	2.42	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	370.26	2.59	2.07	2.07	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	403.81	7.97	5.31	2.66	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	397.11	3.33	3.59	0.77	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	452.24	7.16	9.71	1.53	2.30	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	566.40	10.60	3.79	1.51	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	384.79	9.75	3.36	0.34	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	556.91	6.04	6.76	2.17	1.69	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	497.80	7.58	8.47	0.89	2.23	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	574.64	6.34	3.90	0.98	1.95	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	543.69	4.89	7.33	1.83	1.83	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1750.24	35.79	100.85	22.77	26.03	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	559.29	3.64	9.27	1.32	1.32	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	554.41	5.47	5.47	0.55	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	441.86	3.62	2.53	0.72	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	408.18	3.20	1.07	1.42	1.42	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	435.59	7.16	7.16	0.00	4.77	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	622.82	3.39	4.20	1.63	1.63	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	353.72	5.93	1.89	1.08	0.27	0.54
immature langerhans cells, donor1	11904-125F5	10.41	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	51.49	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	1407.86	3.12	5.58	5.02	4.45	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	148.27	1.30	0.98	1.30	0.00	0.65
kidney, adult, pool1	10017-101C8	907.15	3.80	4.31	4.21	2.80	0.70
kidney, fetal, pool1	10045-101F9	1021.28	2.12	3.68	2.05	2.41	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	388.57	2.27	1.14	0.85	0.28	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	366.62	3.59	5.81	2.21	1.94	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	199.83	0.92	0.00	1.28	0.73	0.18
left atrium, adult, donor1	10079-102A7	229.38	5.45	1.63	2.72	3.27	1.09
left ventricle, adult, donor1	10078-102A6	174.45	2.02	4.55	1.01	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	175.38	1.64	1.09	1.37	0.82	0.55
leiomyoma cell line:10964C	10569-108B2	249.32	5.75	3.59	2.51	1.80	1.08
leiomyoma cell line:15242A	10570-108B3	247.28	7.61	5.43	1.63	2.72	0.54
leiomyoma cell line:15425	10571-108B4	307.89	8.01	8.26	3.16	5.10	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	279.37	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	272.89	1.05	5.23	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	314.51	3.19	1.77	1.30	1.53	0.94
liposarcoma cell line:KMLS-1	10782-110G8	228.22	5.47	2.19	0.78	0.78	0.94
liposarcoma cell line:SW 872	10726-110A6	373.44	1.83	3.29	0.85	1.34	1.22
liver, adult, pool1	10018-101C9	308.89	0.65	2.11	1.78	0.65	0.32
liver, fetal, pool1	10086-102B5	74.32	0.94	4.70	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	601.53	7.73	6.27	7.87	4.23	1.31
locus coeruleus, adult, donor10252	10165-103B3	744.66	15.87	10.89	8.67	5.91	1.66
locus coeruleus, adult, donor10258	10375-105G6	484.43	8.18	8.75	5.92	4.51	2.26
locus coeruleus, newborn, donor10223	10362-105F2	392.44	3.79	2.94	2.94	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	199.84	0.83	0.28	0.42	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	150.29	0.00	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	833.47	2.50	6.99	4.35	4.09	1.45
lung, adult, pool1	10019-101D1	396.20	1.06	1.42	1.54	0.59	0.35
lung, fetal, donor1	10068-101I5	1163.03	2.00	2.85	4.00	2.28	2.00
lung, right lower lobe, adult, donor1	10075-102A3	216.28	5.50	7.33	1.37	2.29	1.37
lymph node, adult, donor1	10077-102A5	106.03	2.37	0.95	1.42	2.37	0.95
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	644.77	5.10	4.25	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	84.80	0.00	0.44	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	103.14	0.00	0.00	0.62	0.00	0.00
mature adipocyte, donor3	12233-129G1	59.50	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	62.38	0.00	0.26	0.26	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	614.23	2.62	0.95	1.91	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	962.21	18.05	9.02	9.02	6.77	9.02
medial frontal gyrus, adult, donor10252	10150-102I6	751.99	14.16	10.67	19.13	7.54	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	739.58	20.01	9.85	7.31	5.08	5.08
medial frontal gyrus, newborn, donor10223	10352-105E1	752.32	2.56	23.88	10.66	11.52	6.82
medial temporal gyrus - adult, donor10196	10183-103D3	921.38	30.88	38.31	15.86	15.36	5.40
medial temporal gyrus, adult, donor10252	10156-103A3	794.14	11.46	11.04	18.25	7.00	2.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	990.10	5.78	13.48	11.56	5.78	25.04
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	4550.10	157.89	86.12	86.12	143.54	129.18
medial temporal gyrus, newborn, donor10223	10353-105E2	846.36	2.15	5.74	1.44	2.51	4.31
medulla oblongata - adult, donor10196	10174-103C3	565.26	9.09	3.89	3.89	3.24	2.60
medulla oblongata, adult, donor10252	10155-103A2	768.29	10.37	9.29	8.36	3.56	0.93
medulla oblongata, adult, pool1	10038-101F2	919.04	2.04	3.43	4.00	3.35	0.98
medulla oblongata, newborn, donor10223	10361-105F1	432.24	4.17	4.17	2.78	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	110.48	0.66	0.66	0.89	0.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	229.51	0.86	0.49	0.98	0.86	0.98
melanoma cell line:COLO 679	10514-107E1	195.78	1.44	0.86	0.43	0.29	0.29
melanoma cell line:G-361	10465-106H6	323.04	11.94	4.07	2.17	1.63	1.09
meningioma cell line:HKBMM	10691-109F7	304.46	4.34	10.13	2.53	3.26	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	166.54	5.29	2.64	0.00	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	469.19	3.89	4.15	1.56	1.30	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	179.36	2.92	1.53	0.15	0.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	275.94	5.09	2.18	0.55	2.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	218.65	6.21	2.90	0.83	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	224.48	3.65	1.97	0.56	0.14	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	273.45	4.62	1.35	0.96	1.16	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	357.45	8.33	2.08	1.39	0.00	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	408.83	2.75	4.12	1.37	2.06	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	300.88	4.26	3.22	1.38	0.92	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	215.40	2.25	1.86	0.93	0.93	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	337.60	6.48	2.84	0.95	0.81	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	396.20	4.13	4.13	2.56	1.28	1.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	475.92	6.26	1.65	0.33	0.99	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	278.82	1.94	2.08	1.11	0.55	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	324.65	10.82	2.09	2.44	1.40	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	334.63	7.76	3.88	1.84	1.02	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	412.65	9.35	0.72	2.88	0.72	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	266.38	3.62	1.76	0.41	0.72	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	475.59	9.35	4.56	2.74	2.74	3.19
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	706.53	13.01	3.36	2.52	2.94	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	370.01	3.29	3.14	0.75	1.05	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	304.69	5.43	2.80	0.88	0.88	0.88
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	488.92	2.21	2.95	1.84	1.10	3.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	461.00	12.88	4.01	3.43	3.43	2.58
mesenchymal stem cell line:Hu5/E18	10568-108B1	206.72	5.05	4.21	2.11	1.68	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	175.82	2.28	1.37	0.00	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	167.28	3.84	3.07	0.51	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	193.96	4.19	0.79	1.31	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	187.32	1.85	3.08	0.62	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	174.16	3.06	2.82	0.47	0.71	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	205.44	2.71	1.69	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	180.77	1.96	3.14	0.79	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	174.23	1.39	2.78	0.93	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	214.87	2.31	1.73	1.15	0.29	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	205.70	3.35	1.56	0.22	0.89	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	191.80	2.88	3.36	0.72	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	205.33	1.47	4.40	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	182.93	3.36	3.02	0.34	1.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	186.68	1.23	0.41	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	211.34	2.58	2.15	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	213.28	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	247.92	5.16	15.49	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	213.71	1.62	1.95	1.95	0.32	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	202.24	1.45	1.45	2.91	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	187.64	3.20	2.67	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	178.27	5.72	4.91	0.82	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	199.41	5.44	1.55	1.17	0.78	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	201.48	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	246.38	0.99	3.97	0.00	0.00	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	209.76	4.77	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	202.79	4.74	5.34	1.19	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	220.54	1.22	3.66	0.00	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	270.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	206.48	3.17	3.17	1.27	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	225.91	2.76	3.10	1.03	3.10	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	249.31	0.00	8.60	4.30	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	223.54	0.00	3.99	11.98	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	199.75	10.33	6.89	6.89	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	200.48	4.48	3.26	2.04	2.04	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	197.02	4.77	3.97	2.38	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	141.49	2.95	2.95	0.59	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	147.44	4.05	1.25	0.94	1.56	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	172.43	2.67	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	117.08	4.73	1.18	3.55	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	146.38	5.14	2.57	2.57	5.14	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	154.89	2.07	6.88	0.00	2.07	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	117.76	1.48	2.47	0.49	1.48	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	93.09	2.24	2.24	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	109.40	2.54	2.54	0.64	3.18	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	74.15	0.40	2.01	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	74.14	6.54	0.00	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	79.82	1.27	0.00	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	103.78	0.61	1.82	0.61	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	162.68	13.56	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	92.25	2.47	2.47	0.00	0.82	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	162.31	2.18	1.39	0.20	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	125.58	2.60	1.30	0.65	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	148.72	6.11	3.06	3.06	0.00	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	280.08	1.55	0.00	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	340.66	2.83	0.71	0.94	1.18	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	890.55	9.50	1.85	2.55	2.78	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	337.61	8.55	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	201.80	3.08	1.75	1.13	1.03	0.92
mesothelioma cell line:Mero-25	10850-111F4	345.88	2.27	2.95	1.13	0.68	1.82
mesothelioma cell line:Mero-41	10851-111F5	171.38	2.20	2.44	1.22	1.96	1.22
mesothelioma cell line:Mero-48a	10852-111F6	341.67	3.10	2.44	1.77	1.33	1.77
mesothelioma cell line:Mero-82	10853-111F7	411.29	9.46	7.62	3.68	3.94	3.68
mesothelioma cell line:Mero-83	10854-111F8	586.07	6.64	8.68	4.26	4.43	5.62
mesothelioma cell line:Mero-84	10855-111F9	566.72	5.81	3.29	1.52	2.27	2.53
mesothelioma cell line:Mero-95	10856-111G1	283.86	3.11	2.69	1.86	0.83	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	280.61	3.15	1.49	0.66	1.16	1.16
mesothelioma cell line:NCI-H226	10846-111E9	390.22	5.97	4.16	3.26	1.99	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	448.41	6.15	3.93	1.71	1.54	2.05
mesothelioma cell line:NCI-H28	10845-111E8	349.89	6.62	4.07	0.51	1.78	1.78
mesothelioma cell line:No36	10857-111G2	533.67	8.16	6.20	2.61	3.59	4.24
mesothelioma cell line:ONE58	10858-111G3	383.94	3.25	4.06	2.17	2.44	1.90
migratory langerhans cells, donor1	11901-125F2	9.98	0.00	0.00	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	8.18	0.24	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	10.95	0.00	0.18	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	337.58	17.30	12.08	4.90	4.57	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	118.47	3.81	1.91	0.85	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	199.03	0.69	0.23	0.69	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	68.31	0.95	0.19	0.38	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	349.81	5.91	1.11	0.92	0.37	0.74
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	155.23	0.51	2.54	1.01	1.01	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	79.24	1.18	0.59	0.20	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	396.78	2.34	0.45	0.11	0.78	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	369.10	0.74	1.18	0.37	0.59	0.29
nasal epithelial cells, donor2	12227-129F4	383.08	2.76	0.00	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	427.68	1.38	1.15	1.15	0.69	0.46
neuroblastoma cell line:NB-1	10539-107G8	460.98	2.43	0.56	0.75	1.31	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	1005.31	11.39	8.86	4.43	5.27	7.59
neuroblastoma cell line:NH-12	10555-107I6	445.01	3.17	3.17	1.12	1.68	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	326.66	3.80	4.98	1.42	3.56	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	264.02	6.02	3.64	1.74	1.43	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	192.20	4.43	2.01	2.01	1.01	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	217.43	0.00	1.27	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	146.92	1.86	1.33	0.53	0.80	0.53
neutrophil PMN, donor1	12133-128D9	609.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	185.93	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	151.53	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1013.03	4.90	2.88	3.55	1.86	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	237.75	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	357.48	15.07	6.09	2.24	3.85	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	605.15	14.45	11.30	4.73	6.04	1.31
nucleus accumbens, adult, pool1	10037-101F1	1258.45	3.56	4.12	3.19	2.91	1.97
occipital cortex - adult, donor10196	10172-103C1	834.46	26.78	6.18	8.24	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	653.73	8.86	10.73	13.15	3.76	3.22
occipital cortex, newborn, donor10223	10355-105E4	844.35	2.91	12.37	2.55	2.55	1.46
occipital lobe, adult, donor1	10076-102A4	889.79	16.79	10.23	8.13	6.30	18.89
occipital lobe, fetal, donor1	10073-102A1	668.11	20.60	7.29	5.15	5.58	4.72
occipital pole, adult, pool1	10036-101E9	1027.86	1.73	4.26	2.60	2.13	1.26
olfactory region, adult	10195-103E6	946.66	9.93	19.11	21.78	15.28	11.08
optic nerve, donor1	10277-104E7	998.52	6.00	4.00	8.00	12.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	398.68	2.73	0.80	0.68	0.68	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	112.79	0.55	0.27	0.27	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	423.48	3.89	8.30	5.42	6.10	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	240.26	1.27	2.19	0.81	0.92	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	171.38	1.18	1.18	0.59	1.18	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	530.70	1.87	0.93	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	573.83	3.61	1.48	1.70	0.85	1.27
ovary, adult, pool1	10020-101D2	373.08	1.14	1.40	1.05	0.87	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	488.73	6.05	6.05	5.13	4.40	1.28
pancreas, adult, donor1	10049-101G4	330.16	6.58	4.70	3.76	3.76	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	507.64	5.59	3.35	2.24	1.96	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	510.89	12.27	12.27	6.64	4.94	4.43
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	186.28	0.83	0.99	0.50	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	1241.22	3.39	5.40	3.29	2.29	1.19
parietal cortex, adult, donor10258	10373-105G4	910.17	6.61	9.54	8.07	9.54	11.01
parietal lobe - adult, donor10196	10171-103B9	817.28	17.87	14.11	7.52	8.46	8.46
parietal lobe, adult, donor10252	10157-103A4	767.89	12.83	7.13	17.10	8.55	3.99
parietal lobe, adult, pool1	10034-101E7	1200.01	2.73	4.49	3.88	3.00	1.06
parietal lobe, fetal, donor1	10072-101I9	500.43	20.37	11.64	8.73	5.82	2.91
parietal lobe, newborn, donor10223	10356-105E5	868.85	2.62	7.48	2.24	4.86	1.12
parotid gland, adult	10199-103F1	266.40	1.23	3.70	2.47	3.70	0.62
penis, adult	10200-103F2	283.06	5.37	5.37	5.91	2.69	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	336.92	1.86	3.90	1.67	1.86	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	299.11	3.06	4.52	2.48	2.48	0.73
pineal gland - adult, donor10196	10179-103C8	441.20	5.16	1.29	1.94	1.94	3.23
pineal gland, adult, donor10252	10160-103A7	760.40	7.70	4.74	2.96	4.15	2.96
pineal gland, adult, donor10258	10377-105G8	361.82	3.76	1.88	5.02	1.88	1.88
pituitary gland - adult, donor10196	10180-103C9	505.90	4.05	1.01	3.04	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	735.38	0.52	1.56	3.65	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	303.89	6.81	4.26	1.70	1.70	0.00
placenta, adult, pool1	10021-101D3	439.36	1.40	0.97	1.51	0.54	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	162.62	0.93	1.85	0.53	0.79	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	115.48	2.49	0.16	0.31	0.31	0.47
pons, adult, pool1	10033-101E6	971.79	3.36	2.84	3.27	3.01	0.43
postcentral gyrus, adult, pool1	10032-101E5	1147.32	3.84	5.49	2.96	2.70	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	905.57	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	280.91	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	199.51	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	502.39	10.34	3.20	1.60	2.04	1.17
prostate cancer cell line:PC-3	10439-106E7	778.28	11.43	4.54	2.54	3.81	2.54
prostate, adult, pool1	10022-101D4	406.12	0.91	2.09	1.00	0.36	0.18
putamen, adult, donor10196	10176-103C5	1432.43	20.07	21.48	12.04	8.03	2.60
putamen, adult, donor10252	10152-102I8	747.04	9.80	3.92	17.65	9.80	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	601.05	7.65	6.56	5.46	4.37	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	991.82	12.08	9.66	13.29	8.21	6.52
putamen, newborn, donor10223	10365-105F5	356.09	0.75	7.50	3.00	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	430.58	0.87	1.16	2.33	1.75	0.29
rectum, fetal, donor1	10067-101I4	399.21	4.17	1.39	8.35	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	325.84	3.39	0.64	0.85	1.27	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	535.57	17.40	6.21	2.07	2.90	2.90
retina, adult, pool1	10030-101E3	669.55	2.39	3.18	2.58	1.89	0.40
retinoblastoma cell line:Y79	10475-106I7	185.76	1.56	1.56	0.26	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	359.38	4.06	1.84	1.60	2.09	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	417.30	4.50	1.41	1.41	1.41	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	411.51	1.52	1.52	3.03	0.76	0.76
salivary acinar cells, donor1	11771-123I7	701.32	5.34	8.25	2.91	3.56	2.75
salivary acinar cells, donor2	11772-123I8	537.12	4.41	9.36	2.62	3.17	1.79
salivary acinar cells, donor3	11773-123I9	311.16	1.32	7.94	2.65	1.32	0.66
salivary gland, adult, pool1	10093-102C3	342.03	1.72	2.86	0.57	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	289.53	2.95	1.35	0.67	0.42	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	256.97	4.11	1.29	1.18	1.18	1.41
seminal vesicle, adult	10201-103F3	659.22	8.99	8.47	14.81	14.28	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	420.75	6.32	10.69	4.62	1.94	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	393.55	1.76	2.01	0.75	1.76	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	268.95	7.02	2.01	0.00	2.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	617.07	7.52	6.04	2.42	3.22	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	508.87	2.65	0.99	1.11	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	314.18	2.97	1.55	0.39	0.39	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	73.06	0.71	1.42	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	148.60	0.36	0.72	0.96	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	120.60	1.01	2.01	2.01	2.01	0.00
skin, adult, donor1	10074-102A2	189.99	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	398.94	5.05	1.89	2.52	2.52	6.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	233.80	4.00	1.67	1.33	1.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	274.54	6.93	5.67	2.21	2.84	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	360.82	3.47	5.40	0.77	1.54	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	740.07	3.30	1.65	1.32	1.65	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	221.81	1.29	1.61	1.45	1.13	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	496.42	1.31	2.40	2.18	3.49	1.09
small intestine, adult, pool1	10024-101D6	369.44	1.43	1.67	1.31	1.07	0.60
small intestine, fetal, donor1	10064-101I1	201.72	6.88	3.44	0.98	1.97	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	460.59	8.72	11.80	0.51	2.56	2.05
smooth muscle, adult, pool1	10048-101G3	371.66	4.39	8.27	4.65	1.03	1.29
somatostatinoma cell line:QGP-1	10781-110G7	316.26	0.54	1.07	0.54	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	507.68	11.70	13.76	7.11	5.05	3.90
spinal cord, adult, donor10252	10159-103A6	573.27	5.13	4.34	5.52	3.55	1.18
spinal cord, adult, donor10258	10369-105F9	572.81	6.92	9.69	5.53	2.08	6.23
spinal cord, fetal, donor1	10056-101H2	665.94	11.59	5.49	6.10	6.71	6.71
spinal cord, newborn, donor10223	10359-105E8	555.65	2.30	4.13	5.97	4.13	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	196.40	2.69	1.34	0.60	0.75	0.30
spleen, adult, pool1	10025-101D7	254.30	0.77	0.66	0.99	0.99	0.44
spleen, fetal, pool1	10044-101F8	331.17	0.48	0.87	0.48	0.40	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	188.81	0.93	0.52	0.31	0.72	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	300.57	1.71	1.52	0.76	0.95	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	494.13	12.93	13.28	5.59	4.89	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	352.23	1.56	5.86	1.56	1.95	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	169.96	2.48	0.34	0.23	0.45	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	120.73	1.69	0.42	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	267.80	1.69	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	401.56	2.14	3.20	1.07	1.07	2.14
submaxillary gland, adult	10202-103F4	337.25	0.57	1.71	1.71	1.71	2.28
substantia nigra - adult, donor10196	10178-103C7	1573.95	759.84	325.64	542.74	162.82	542.74
substantia nigra, adult, donor10252	10158-103A5	817.32	16.62	12.25	8.31	6.65	3.32
substantia nigra, adult, donor10258	10371-105G2	868.98	6.21	7.24	8.28	3.10	4.14
substantia nigra, newborn, donor10223	10358-105E7	435.96	2.83	2.12	3.53	2.12	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	415.20	8.94	2.75	2.06	1.38	1.38
temporal lobe, adult, pool1	10031-101E4	1122.02	3.48	5.59	3.65	2.97	1.53
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	554.14	14.25	4.99	2.85	4.27	9.26
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	716.01	9.23	2.20	3.52	4.83	14.07
tenocyte, donor1	11763-123H8	283.82	9.43	7.68	2.79	2.44	3.49
tenocyte, donor2	11765-123I1	158.71	4.96	4.96	1.14	0.76	1.14
tenocyte, donor3	11768-123I4	165.32	6.30	4.45	1.48	3.34	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	538.60	4.08	5.78	0.85	3.40	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	123.16	1.85	1.23	0.62	0.92	0.77
teratocarcinoma cell line:PA-1	10807-111A6	298.95	6.20	1.08	1.70	1.86	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	365.35	3.17	2.03	1.78	1.02	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1151.16	10.97	6.81	4.16	3.40	3.40
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	788.41	4.04	8.94	3.60	3.49	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	693.10	9.45	20.84	5.21	8.79	3.26
testis, adult, pool1	10026-101D8	415.32	1.40	5.26	1.72	1.29	0.32
testis, adult, pool2	10096-102C6	514.24	8.57	13.98	5.41	5.86	4.96
thalamus - adult, donor10196	10168-103B6	942.80	13.25	7.73	6.62	1.10	3.31
thalamus, adult, donor10252	10154-103A1	927.70	9.53	9.38	8.13	5.63	3.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	980.74	10.78	13.86	3.08	3.08	13.86
thalamus, adult, donor10258, tech_rep2	10370-105G1	406.45	9.39	6.09	4.94	5.76	2.96
thalamus, newborn, donor10223	10366-105F6	687.51	6.90	2.88	2.88	4.60	1.15
throat, adult	10209-103G2	260.90	1.25	3.00	1.75	2.75	1.75
throat, fetal, donor1	10061-101H7	419.58	7.01	5.18	3.05	5.79	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	181.24	1.79	0.20	0.00	0.79	1.19
thymus, adult, pool1	10027-101D9	164.33	0.30	0.99	0.40	0.20	0.10
thymus, fetal, pool1	10043-101F7	286.57	0.42	0.94	0.83	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	256.48	2.66	1.86	0.40	1.20	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	264.99	3.49	2.93	1.68	1.26	1.12
thyroid, adult, pool1	10028-101E1	845.98	4.57	2.89	2.33	2.24	0.84
thyroid, fetal, donor1	10060-101H6	510.19	8.44	12.66	10.28	6.59	4.22
tongue epidermis (fungiform papillae), donor1	10288-104F9	329.52	3.08	0.00	3.08	15.40	3.08
tongue, adult	10203-103F5	191.88	0.70	3.72	1.40	2.79	1.16
tongue, fetal, donor1	10059-101H5	210.84	7.88	1.58	1.97	1.18	0.39
tonsil, adult, pool1	10047-101G2	226.40	0.60	0.60	0.50	0.50	0.00
trachea, adult, pool1	10029-101E2	332.84	1.55	1.64	0.98	1.06	0.08
trachea, fetal, donor1	10058-101H4	408.93	5.00	5.39	3.46	4.23	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	153.05	4.96	0.00	0.71	1.42	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	418.54	1.93	1.32	1.42	0.20	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	511.43	7.52	4.54	1.88	2.35	1.10
tridermal teratoma cell line:HGRT	10694-109G1	239.72	1.90	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	219.33	1.35	1.69	1.02	0.76	1.02
umbilical cord, fetal, donor1	10057-101H3	502.85	4.17	4.17	4.17	2.09	2.09
uterus, adult, pool1	10100-102D1	540.38	2.22	1.71	1.19	0.51	0.85
uterus, fetal, donor1	10055-101H1	390.60	5.12	8.70	4.61	2.56	0.51
vagina, adult	10204-103F6	539.58	1.29	7.75	0.00	1.29	0.65
vein, adult	10191-103E2	259.97	1.53	2.19	1.32	2.41	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.27	0.00	0.00	0.00	0.00	0.00